This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Delaware. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Nick Levy: Innovator in Recombinant Protein Production
Introduction
Nick Levy is an accomplished inventor based in Philadelphia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein production. With a total of 2 patents, his work has the potential to impact various applications in the industry.
Latest Patents
One of Nick Levy's latest patents focuses on the reduction of lipase activity in product formulations. This invention relates to a method for producing a stable recombinant protein. The process involves growing a non-naturally occurring host cell in a culture medium to produce the recombinant protein. Additionally, it includes making a composition that comprises the recombinant protein and a polysorbate. The production of endogenous lipoprotein lipase by the host cell is reduced, ensuring that the endogenous lipoprotein lipase present in the composition is in a small amount and capable of degrading the polysorbate. This invention also encompasses the relevant host cells, compositions, and their preparation.
Career Highlights
Nick Levy is affiliated with the University of Delaware, where he continues to advance his research and innovations. His work has garnered attention for its practical applications in biotechnology and product formulation.
Collaborations
Throughout his career, Nick has collaborated with notable colleagues, including Kelvin Lee and Abraham Lenhoff. These partnerships have contributed to the development of his innovative ideas and patents.
Conclusion
Nick Levy is a prominent figure in the field of recombinant protein production, with a focus on reducing lipase activity in formulations. His contributions through his patents and collaborations highlight his commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
